Table 3.
Pathogen | Compound/Extract/EO | Activity | Reference Antibiotic | Ref | |
---|---|---|---|---|---|
Antibiotic | Activity | ||||
Candida albicans | Extract | MIC 0.25 mg/mL | [124] | ||
C. albicans | Extract | MIC 1.42 mg/mL | Fluconazole | MIC 2 mg/mL | [99] |
C. albicans | 4-terpenyl cannabinolate | MIC 8.5 µg/mL | [125] | ||
C. albicans | 8-hydroxycannabinol | IC50 4.6 µM | Amphotericin B | IC50 0.3 µM | [96] |
C. albicans | Cannabis and ginger blend | MIC 4.69 mg/mL | [126] | ||
C. albicans | CBDV | IC50 11.9 mM | Nystatin | IC50 1.50 mM | [97] |
C. albicans | CBNA | IC50 8.5 µg/mL | [125] | ||
Candida krusei | Cannabinoids | IC50 53.4–60.5 µM | amphotericin B | IC50 0.7 µM | [96] |
Candida neoformans | β-caryophyllene/oxide | IC50 1.18–19.4 µg/mL | [98] | ||
Candida species | β-caryophyllene | MIC 1.45–10.0 µg/mL | [98] | ||
Plasmodium falciparum | Cannabinoids | IC50 4.0–6.7 µM | Chloroquine | IC50 0.1–0.5 µM | [96] |
P. falciparum | CBNA | IC50 2.4–2.7 µg/mL | [125] | ||
Trichophyton and Arthroderma species | EO | MIC 0.312–6.3 µg/mL | Griseofulvin | MIC 1.26 to >8.0 µg/mL | [123] |